Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017:1:e1-e6.
doi: 10.9777/rr.2017.10003. Epub 2017 Nov 18.

Androgen metabolism genes in prostate cancer health disparities

Affiliations

Androgen metabolism genes in prostate cancer health disparities

Wei Liu et al. Cancer Health Disparities. 2017.

Abstract

For men in the United States, prostate cancer is common, and newly diagnosed cases of prostate cancer outnumber those of all other cancer types. For prostate cancer, there are racial disparities between Caucasian Americans and African Americans. Androgens and androgen metabolism may be involved in these disparities as well as in the initiation and progression of prostate cancer. Here, we analyzed, in the Cancer Genome Atlas (TCGA) database, the mRNA expression of genes involved in androgen metabolism in prostate cancer based on the patient's race. The results revealed that expressions of UGT2B15 and CYP3A5 are higher but that SRD5A2, CYP17A1, HSD3B2, and AKR1C3 are lower in African American prostate cancers than in those of Caucasian Americans. These genes may relate to the racial disparities associated with prostate cancer. However, the evidence require validation and functional analysis.

Keywords: androgen; gene expression; metabolism; prostate cancer; racial disparity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
mRNA expression of genes involved in androgen metabolism in normal prostate tissues and prostate cancers based on the race of patients as determined with the TCGA database. CA, Caucasian American; AA, African American.

Similar articles

Cited by

References

    1. Bremmer F, Jarry H, Strauss A, Behnes CL, Trojan L, Thelen P. Increased expression of CYP17A1 indicates an effective targeting of the androgen receptor axis in castration resistant prostate cancer (CRPC) Springerplus. 2014;3:574. - PMC - PubMed
    1. Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, Varambally S. UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses. Neoplasia. 2017;19:649–658. - PMC - PubMed
    1. Chang KH, Ercole CE, Sharifi N. Androgen metabolism in prostate cancer: from molecular mechanisms to clinical consequences. Br J Cancer. 2014;111:1249–1254. - PMC - PubMed
    1. Cooper LA, Page ST. Androgens and prostate disease. Asian J Androl. 2014;16:248–255. - PMC - PubMed
    1. Dozmorov MG, Azzarello JT, Wren JD, Fung KM, Yang Q, Davis JS, Hurst RE, Culkin DJ, Penning TM, Lin HK. Elevated AKR1C3 expression promotes prostate cancer cell survival and prostate cell-mediated endothelial cell tube formation: implications for prostate cancer progression. BMC Cancer. 2010;10:672. - PMC - PubMed

LinkOut - more resources